INAB
IN8BIO (INAB)
NASDAQ
$1.55+$0.005 (+0.32%)
Price as of Jun 03, 2026 7:58 PM EDT
  • $18.4M
    Market Cap
  • -57.96%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-10.2M
-39.80%
-17.0M
+0.80%
-16.8M
+19.66%
-14.1M
+91.40%
Depreciation and Amortization Expense
1.0M
+2.46%
976,000
+1.46%
962,000
+554.42%
147,000
+65.17%
Total Operating Expenses
19.9M
-35.24%
30.7M
+1.09%
30.3M
+6.37%
28.5M
+94.64%
Operating Profit
-19.4M
-36.13%
-30.4M
+0.33%
-30.3M
+6.37%
-28.5M
+94.64%
Interest Income
421,000
+83.04%
230,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
421,000
+83.04%
230,000
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
0
-100.00%
330,000
N/A
N/A
N/A
Income before Taxes
-19.4M
-36.13%
-30.4M
+0.33%
-30.3M
+6.37%
-28.5M
+94.64%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-19.4M
-36.13%
-30.4M
+1.43%
-30.0M
+5.21%
-28.5M
+94.64%
Net Income from Continuing Operations Applicable to Common
-19.4M
-36.13%
-30.4M
+1.43%
-30.0M
+5.21%
-28.5M
+94.64%
Basic EPS and Net Income
-4.44
+678.95%
-0.57
-43.00%
-1.00
-26.47%
-1.36
-7.48%
Diluted EPS and Net Income
-4.44
+678.95%
-0.57
-43.00%
-1.00
-26.47%
-1.36
-7.48%
Basic Weighted Average Shares
4.4M
-91.83%
53.5M
+79.30%
29.9M
+42.43%
21.0M
+110.32%
Diluted Weighted Average Shares
4.4M
-91.83%
53.5M
+79.30%
29.9M
+42.43%
21.0M
+110.32%
Balance Sheet
Cash and Cash Equivalents
27.1M
+143.63%
11.1M
-47.75%
21.3M
+17.05%
18.2M
-50.89%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
27.1M
+143.63%
11.1M
-47.75%
21.3M
+17.05%
18.2M
-50.89%
Total Current Assets
27.9M
+121.66%
12.6M
-48.92%
24.6M
+10.75%
22.2M
-42.96%
Accumulated Depreciation
3.2M
+41.36%
2.3M
+76.38%
1.3M
+299.69%
321,000
-7.23%
Property and Plant and Equipment and Net
1.9M
-34.99%
2.9M
-18.67%
3.5M
-20.08%
4.4M
+4,432.99%
Total Long-Term Assets
4.4M
-47.38%
8.4M
-7.90%
9.1M
-15.93%
10.8M
+233.18%
Total Assets
32.3M
+54.13%
20.9M
-37.87%
33.7M
+2.03%
33.0M
-21.75%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
3.2M
+2.53%
3.1M
-42.83%
5.4M
-7.37%
5.8M
+158.07%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
200,000
0.00%
Total Long-Term Liabilities
1.6M
-53.80%
3.4M
+0.12%
3.4M
-24.66%
4.5M
+151.40%
Total Liabilities
4.7M
-26.94%
6.5M
-26.29%
8.8M
-14.89%
10.3M
+155.12%
Retained Earnings
-141.1M
+15.98%
-121.7M
+33.37%
-91.2M
+49.02%
-61.2M
+87.24%
Total Stockholders Equity
27.6M
+90.34%
14.5M
-41.94%
24.9M
+9.70%
22.7M
-40.47%
Total Shares Outstanding
9.8M
-86.53%
72.5M
+67.45%
43.3M
+76.36%
24.5M
+30.69%
Cash Flow
Cash from Operating Activities
-12.7M
-47.36%
-24.1M
+3.47%
-23.3M
-3.24%
-24.1M
+78.56%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
+100.00%
-187,000
-68.83%
-600,000
-83.81%
-3.7M
+1,099.03%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
28.6M
+101.90%
14.2M
-47.55%
27.0M
+200.89%
9.0M
-72.73%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-73.05%
-34.42%
-111.38%
+23.88%
-89.91%
+18.63%
-75.79%
N/A
Return on Equity
-92.49%
-40.11%
-154.44%
+22.67%
-125.90%
+34.45%
-93.64%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
8.82
+116.19%
4.08
-10.65%
4.57
+19.56%
3.82
N/A
Cash Ratio
8.57
+137.62%
3.61
-8.60%
3.95
+26.36%
3.12
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow